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ORIGINAL ARTICLE
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ABSTRACT
Purpose: In Ethiopia, trachoma is a major public health problem, accounting for 11.5% of all cases
of blindness. In Gambella, one of the country’s most remote regions, the 2005–2006 National
Survey of Blindness, Low Vision and Trachoma estimated a region-level prevalence of active
trachoma of 19.1% in those aged 1–9 years. Detailed district or sub-regional level estimates are
required to implement interventions.
Methods: Population-based prevalence surveys were carried out following a 2-stage cluster
random sampling methodology and Global Trachoma Mapping Project protocols. As the 13
districts (woredas) in Gambella had relatively small populations, they were grouped together to
form three evaluation units (EUs) of about 100,000 persons each, and all subsequent survey
planning and sampling was carried out at EU-level.
Results: Altogether, 558 cases of TF (17.2%) were identified in 3238 children aged 1–9 years across
the three EUs. The adjusted TF prevalences in 1–9-year-olds for the three EUs were 11.5%, 12.5%
and 19.3%; 14.4% for Gambella overall. A total of 142 cases of trichiasis (3.8%) were identified
among 3781 adults aged 15 years or older, with age- and sex-adjusted EU-level trichiasis
prevalences in adults being 0.8%, 1.3% and 2.4%; 1.5% overall.
Conclusion: The high prevalences of TF and trichiasis throughout Gambella indicate a need for
rapid scaling up of the World Health Organization SAFE strategy (surgery, antibiotics, facial
cleanliness, and environmental improvement) to help meet the 2020 target of global elimination
of trachoma as a public health problem.
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Introduction
Trachoma is caused by ocular infection with the obligate
intracellular bacterium Chlamydia trachomatis. It is the
leading infectious cause of blindness, responsible for
1.4% of all blindness worldwide.1 According to estimates
for 2011, 7.3 million people worldwide have trichiasis,
the potentially blinding stage of the disease.2 In addition
to causing blindness, trachoma limits access to educa-
tion and prevents individuals from being able to work or
care for themselves or their families. Trachoma can have
a detrimental effect on the economic well-being of com-
munities, with conservative estimates suggesting a total
loss of productivity due to trachoma for the visually
impaired or blind and their caregivers of between $3
billion and $8 billion annually.3
In Ethiopia, trachoma is a major public health pro-
blem, accounting for 11.5% of all cases of blindness.4 It is
endemic in all regions, with an estimated 65 million
people at risk.4 There is an urgent need to complete the
map of trachoma globally to appropriately target
resources towards the goal of elimination as a public
health problem by the year 2020. The World Health
Organization (WHO) simplified trachoma grading
system5,6 was designed to be an effective tool for use in
large-scale public health surveys. In this scheme, tracho-
matous inflammation – follicular (TF) is said to be pre-
sent if five or more follicles each >0.5 mm in diameter
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are present in the central upper tarsal conjunctiva. If
greater than half the normal deep tarsal vessels are
obscured by pronounced inflammatory thickening,
then the sign trachomatous inflammation – intense
(TI) is present. If at least one eyelash touches the eyeball,
then trichiasis is present.
The Global Trachoma Mapping Project (GTMP)7
aimed to complete the map of trachoma in all suspected-
endemic districts worldwide. District-level TF prevalence
in children aged 1–9 years is the key indicator for deter-
mining the requirement for three of four components of
the SAFE strategy (surgery, antibiotics, facial cleanliness,
and environmental improvement); A, F, and E.8,9 A dis-
trict, in the context of the statement above, represents the
normal administrative unit for health care management,
which for purposes of clarification consists of a population
unit between 100,000 and 250,000 people.10 The prevalence
of trichiasis in adults aged 15 years and older is helpful for
planning surgical interventions, the S component of the
SAFE strategy.8,9
Gambella is one of the most remote and underdeve-
loped regions in Ethiopia. The region is located on the
western tip of the country and borders South Sudan to
the west, south and north, Oromia Region to the north-
east, and the Southern Nations, Nationalities and People’s
Region (SNNPR) to the east. It covers an area of 25,802km2
and has an estimated population of 383,000, of whom 70%
live in rural areas.11 The administrative structure in
Gambella consists of two zones, subdivided into 13 districts
(woredas). According to the national health indicator
report (2012/13), household-level access to any kind of
sanitation facility is 34% in Gambella.12 There is only one
hospital in the region, supported by 28 health centers and
105 rural health posts. The health force includes 14 physi-
cians, 49 health officers, and 500 nurses.12
Trachoma surveys in Gambella have been difficult to
plan and conduct due to the remote terrain, and transmis-
sion of trachoma in Gambella may be influenced by influ-
xes of refugees from neighboring South Sudan, where
trachoma is hyper-endemic.13,14 A study in 2012 found
99 cases of trachomatous trichiasis (19.2%) from only 515
people examined in a refugee camp in Fugnido,
Gambella,15 and the 2005–2006 National Survey of
Blindness, Low Vision and Trachoma estimated a regional
prevalence of active trachoma (TF and/or TI) in Gambella
of 19.1% in those aged 1–9 years.16
Eye care services in Gambella are severely limited,
with only one ophthalmic nurse for the region and no
integrated eye care workers or ophthalmologists. Data
on eye care from health facilities are scarce. Although
one Gambella zone (Nuer) was listed as a priority for
the first phase of the Ethiopian national program for
trachoma mapping in 2010–2011, there was no woreda-
level mapping of trachoma in the region prior to 2013.
We carried out population-based prevalence surveys
covering all woredas in Gambella. Because woreda popu-
lations were low, the 13 woredas were grouped into three
evaluation units (EUs), each comprising populations of
approximately 100,000 inhabitants, and all subsequent
survey planning and sampling was carried out at EU-
Figure 1. Evaluation unit boundaries, Global Trachoma Mapping Project, Gambella, Ethiopia, 2013–2014.
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level (Figure 1). Figure 1 first mention. The objectives of
this study were to estimate the EU-level TF prevalence in
children aged 1–9 years, and the EU-level trichiasis pre-
valence in those aged 15 years and older.
Materials and methods
Ethics
Ethics clearance was obtained from the ethics committees
of the Gambella Health Bureau (To/9666/06), the London
School of Hygiene & Tropical Medicine (6319), and the
Johns Hopkins Bloomberg School of Public Health. Zonal
and woreda health officers approved plans for community
sensitization before survey teams arrived at each village
(kebele). Informed verbal consent was obtained from
household heads and from each individual aged ≥15
years. For those aged between 7 and 15 years, informed
verbal assent along with parental or guardian consent was
obtained. For those younger than 7 years, parental or
guardian verbal consent was considered acceptable.
All individuals found to have active trachoma were
provided with 1% tetracycline eye ointment to apply
twice daily for 6 weeks, and those with trichiasis were
referred to the nearest health institution for appropriate
management. Residents of selected villages were informed
that they had the right not to participate in the survey, not
to respond to uncomfortable questions and to stop
responding to questions or terminate the examination at
any time, without impacting on their normal health care.
Survey sampling
GTMP standard protocols have been described
elsewhere.7 We used a 2-stage cluster random sampling
methodology. All 13 woredas in Gambella were
included, with each woreda contributing clusters to its
EU in proportion to its population size. Urban areas,
defined as localities with 2000 or more inhabitants, and
all region, zone, and woreda administrative capitals,
were excluded from the sampling frame.11
At the first stage of sampling, clusters (kebeles) were
randomly selected with a probability proportional to
their population size. Kebeles are organized in gares
(clusters of 25–35 households). On the day of field-
work, a gare was selected from the list of gares in the
kebele obtained from local leaders or healthcare work-
ers. Starting from the household first reached in a gare,
all households in a gare until 30 households were
reached were included. In cases where a gare had <30
households, the survey team continued with the next
household in the neighboring gare and proceeded until
30 households were reached. This procedure was varied
for Akobo woreda because at the time of the survey,
people normally resident in Akobo were displaced from
their homes due to unrest in neighboring South Sudan,
and had been housed in temporary settlement camps.
For Akobo, we selected the required number of house-
holds using systematic sampling, with a list of heads of
households in camps supplied by the Regional Health
Bureau as the sampling frame.
Teams went from house to house. All residents of
selected households aged 1 year or older were eligible
for inclusion in the surveys. Graders examined each
consenting person using the WHO simplified trachoma
grading system5,6 (Table 1).
Sample size
To estimate the prevalence of TF in children aged 1–9
years with 95% confidence at the 10% level with preci-
sion of ±3%, a sample size of 1.019 children was
needed.7 Inflating this by 1.2 for non-response means
that we needed to select sufficient households to reach
1222 children. With the expectation that a team would
be able to complete 30 households per day, the cluster
size was fixed at 30 households. From the 2007
Gambella census,17 we expected 48 1–9-year-olds for
every 30-household cluster. We therefore estimated we
would need 26 clusters per EU.
Training
Each survey team consisted of a trachoma grader and a
recorder. Graders and recorders were trained using the
standardized GTMP training system (version 2) and had
Table 1. Number of clusters (kebeles) selected from each eva-
luation unit, Global Trachoma Mapping Project, Gambella,
Ethiopia, 2013-2014.
Woredas per
evaluation unit
Rural
populationa, n
Total rural
kebeles, n
Selected
kebelesb, n
Makwey 18,086 18 5
Wantawo 24,329 20 6
Akobo 24,044 20 6
Jore 9,686 13 2
Jikawo 25,736 24 7
Total 101,881 95 26
Godere 42,286 12 8
Mengesh 24,883 17 4
Dima 10,073 17 2
Goge 63,543 19 12
Total 140,785 65 26
Abobo 20,078 17 4
Gambella Zuria 10,212 11 2
Etang 48,430 23 11
Lare 39,841 26 9
Total 118,561 77 26
aRegional health bureau projected estimates from the 2007 Ethiopian
Census.
bNumber of kebeles selected in each woreda was proportional to the
woreda population in a given evaluation unit.
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to pass in-field examinations to be eligible to be survey
team members.7 A standardized field guide in research
ethics was included as part of the training.18 Training of
graders and recorders was carried out in Wolkite, in the
Southern Nations and Nationalities Region of Ethiopia,
from November 28 to December 6, 2013. A total of 13
survey teams were subsequently formed.
Quality control
Two supervisors (ophthalmologists who were GTMP-
certified grader trainers) were deployed with the teams.
Each supervisor was responsible for six or seven teams
and spent at least 1 day with each team during the
mapping period. They ensured proper diagnostic pro-
cedures and data recording. They also reviewed all
teams’ activities at the end of each day and gave feed-
back to team members.
Data management, analysis and reporting
Data were collected using the LINKS app (Task Force
for Global Health, Decatur, GA, USA) on Android
smartphones. The app automatically encrypted data
and transmitted them to a secure server as soon as a
mobile network was available. Anonymized data were
subsequently used for analysis.
A cleaned dataset was reviewed and approved by the
Gambella Health Bureau and Federal Ministry of
Health of Ethiopia. Cluster-level TF prevalences were
adjusted in 1-year age-bands in children aged 1–9
years, with the overall EU-level TF prevalence being
the mean of all adjusted cluster-level prevalences.
Trichiasis cluster-level prevalences in those aged 15
years and older were adjusted for sex and age in 5-
year age-bands using the latest available census data,11
with the overall EU-level trichiasis prevalence estimated
as the mean of all adjusted cluster-level trichiasis pre-
valences. Full details of the analysis are outlined
elsewhere.7
Results
The surveys were carried out from December 18, 2013, to
January 30, 2014. A total of three EUs were surveyed, with
8599 individuals from 2143 households enumerated for
inclusion in the surveys. Of those enumerated, 8018
(93.2%) were examined, and 56 (0.7%) refused. A total of
525 individuals (6.1%) were absent at the time of survey. Of
those examined, 4684 were female (58.4%). Overall, 3324
children aged 1–9 years, and 4185 individuals aged ≥15
years were examined. Themean age of those examined was
19.8 years. The baseline characteristics of those examined
in each EU are presented in Table 2.
Across the three EUs, 558 cases of TF (17.2%) were
identified out of 3238 children aged 1–9 years exam-
ined. The distribution of these cases by EU is shown in
Table 3 and Figure 2. Each EU had a TF prevalence in
those aged 1–9 years above the WHO 10% threshold
for full implementation of the A, F and E components
Table 2. Characteristics of enumerated individuals, Global Trachoma Mapping Project, Gambella, Ethiopia, 2013-2014.
Examined, n Absent, n Refused, n
Evaluation unit All Male Female All Male Female All Male Female Total
Makwey, Wantawo, Akobo, Jore, Jikawo 2,790 1,123 1,667 166 124 42 18 7 11 2,974
Godere, Mengesh, Dima, Gog 2,568 1,088 1,480 192 125 67 15 6 9 2,775
Abobo, Gambela Zuria, Etang, Lare 2,660 1,123 1,537 167 95 72 23 7 16 2,850
Total 8,018 3,334 4,684 525 344 181 56 20 36 8,599
Table 3. Prevalences of trachomatous inflammation — follicular (TF) and trichiasis by evaluation unit, Global Trachoma Mapping
Project, Gambella, Ethiopia, 2013-2014.
Age 1-9 years Age ≥15 years
Evaluation unit
Examined,
n
TF
cases,
n
Unadjusted
TF, %
Adjusteda TF, %
(95% CIb)
Examined,
n
Trichiasis
cases, n
Unadjusted
trichiasis, %
Adjustedc trichiasis, %
(95% CIb)
Makwey, Wantawo, Akobo,
Jore, Jikawo
904 143 15.8 11.5 (7.3-15.3) 1,411 23 1.6 0.8 (0.5-1.2)
Godere, Mengesh, Dima,
Gog
1,301 252 19.4 19.3 (15.2-24.2) 1,165 84 7.2 2.4 (1.7-3.3)
Abobo, Gambela Zuria,
Etang, Lare
1,119 163 14.6 12.5 (9.1-16.1) 1,205 35 2.9 1.3 (0.7-1.9)
Total 3,324 558 16.6 14.4 3,781 142 3.8 1.5
aAdjusted for age by year using Gambella Region data from the Ethiopian Census 2007.
b95% CI estimated by bootstrapping adjusted cluster-level estimates over 10,000 iterations.
cAdjusted for sex and age in 5-year bands using Gambella Region data from the Ethiopian Census 2007.
CI, confidence interval.
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of SAFE, including mass drug administration (MDA) of
azithromycin.
A total of 142 cases of trichiasis (3.8%) were identi-
fied across the three EUs, among 3781 participants
examined who were aged 15 years or older. The esti-
mated sex- and age-adjusted trichiasis prevalence in
those aged 15 years or older is shown for each EU in
Table 3 and Figure 3.
Discussion
There is a moderately high prevalence of trachoma
throughout Gambella, with estimates from these sur-
veys largely in agreement with the 14.6% regional TF
prevalence estimate from the national survey of
2005–2006.16 In the global context, the TF prevalences
recorded here are high, particularly when compared to
the WHO 5% TF elimination threshold, but they are
noticeably lower than TF prevalences in adjacent areas
of SNNPR19 and Oromia.20 TF prevalences above 10%
mandate full implementation of the A, F and E compo-
nents of the SAFE strategy. These interventions should
be continued for 3 years before re-surveying to gauge
the impact of the program.
These are the first high-resolution estimates of
trachoma prevalence in Gambella, and will allow
more accurate estimates to be made of the number
of people with trichiasis needing treatment than have
previously been available. Further work is still needed
to determine the relative impacts of mortality in
unoperated individuals with trichiasis, surgical inter-
ventions, post-surgical recurrence, and incident tri-
chiasis (in the years before the A, F and E
interventions begin to halt progression of trachoma)
on surgical backlog numbers; to avoid fixing a false
target, we have not provided a total surgical backlog
number for the region here. Trichiasis patients are
those at imminent risk of developing irreversible
blindness, and therefore identifying and treating
these patients must be a priority. There is an urgent
need for fundraising, planning, and training to
increase the local capacity to deal with trichiasis
cases over the coming years.
There was some variability in the trichiasis prevalences
between EUs. The reason for this is unclear. However, in
the latest estimates available from the United Nations
High Commissioner for Refugees, Gambella has a refugee
population of 269,853 individuals.21 The degree to which
refugees contribute to the variation in trichiasis preva-
lence is unknown, and further study is required.
Implementation of the SAFE strategy in the refugee and
displaced population is likely to be a challenge, due to
occasional uncertain security, population efflux compli-
cating surgical follow-up, and continuing immigration
compromising the effectiveness of both antibiotic MDA
and facial cleanliness promotion.
Although there are current efforts to improve water
supply and sanitation in Gambella, they are not tied to
Figure 2. Distribution of trachomatous inflammation – follicular (TF) prevalence in 1–9-year-olds at evaluation unit level, Global
Trachoma Mapping Project, Gambella, Ethiopia, 2013–2014.
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trachoma elimination programs. Two ophthalmic
nurses provide trichiasis surgery and occasional com-
munity outreach, but these activities will not be suffi-
cient to address the large backlog of trichiasis surgery
in the region. No MDA for trachoma has yet been
started in Gambella.
A significant up-scaling of efforts is needed to elim-
inate trachoma from Gambella. It is hoped that the
publication of these results can serve to highlight the
need for research, collaboration and funding that will
advance the goal of elimination of trachoma from the
region by 2020.
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